Cargando…
Aplastic anemia following the severe acute respiratory syndrome coronavirus‐2 vaccine
Autores principales: | Babakhanlou, Rodrick, Kadia, Tapan, Chien, Kelly, Sasaki, Koji, Thompson, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877786/ https://www.ncbi.nlm.nih.gov/pubmed/36718353 http://dx.doi.org/10.1002/jha2.602 |
Ejemplares similares
-
P807: APLASTIC ANEMIA FOLLOWING THE SARS-COV-2 VACCINE
por: Babakhanlou, R., et al.
Publicado: (2022) -
Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation
por: Garnier, Alice, et al.
Publicado: (2022) -
Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
por: Wan, Ziqi, et al.
Publicado: (2023) -
Severe Hepatitis-associated Aplastic Anemia Following COVID-19 mRNA Vaccination
por: Yamamoto, Michio, et al.
Publicado: (2023) -
Severe Aplastic Anemia following Parvovirus B19-Associated Acute Hepatitis
por: Furukawa, Masanori, et al.
Publicado: (2017)